13 Dec 2011 | 11:09 am | 2 min. read
Pinsent Masons, an international law firm which specialises in technology today announced the top five trends it believes will affect UK and global tech businesses in 2012.
“Against a backdrop of challenging market conditions technology businesses need to prepare themselves for an even more competitive year in 2012,” said Andrew Hornigold, head of technology sector, Pinsent Masons. “From our experience and understanding we predict that five key trends around intellectual property, convergence, skills, protecting personal data and incentivising the workforce should be at the forefront of every technology company’s thinking if they are to thrive in the New Year.”
The five trends highlighted by Pinsent Masons, a firm which works with leading technology businesses across the world and helps them prepare for the future through strategic business advice, are:
Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.
Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.
Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).
Multinational law firm Pinsent Masons has announced plans to launch a presence in Amsterdam, its first office in the Netherlands.
Multinational law firm Pinsent Masons has advised the Department for Digital, Culture, Media and Sport (DCMS) on its innovative joint £28m investment in 5G test projects to showcase the capability of 5G technology across a range of industries and identify commercially sustainable long-term use cases.
Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on